A Prospective Multicenter Pivotal Study to Evaluate Safety and Effectiveness of Venus-Neo Surgical Aortic Valve
A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 155 participants.
Also called NCT05941455
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 155 participants
- Sponsor
- Jilin Venus Haoyue Medtech Limited
- Registry
-
NCT05941455
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Germany
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT05941455. Allocation not applicable; no masking; primary purpose treatment. Start 2023-10-31 (anticipated); primary completion 2025-10-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Prospective Multicenter Pivotal Study to Evaluate Safety and Effectiveness of Venus-Neo Surgical Aortic Valve
- Acronym
- METASAR
- Condition
- Aortic Valve Disease
- Condition
- Cardiovascular Diseases
- Intervention (Device)
- Venus-Neo Surgical Aortic Valve
- Lead sponsor
- Jilin Venus Haoyue Medtech Limited
Record details
- Record id
cardio:ct-nct05941455- Content hash
afebefdbadd2318e33e1986b56f169484d15366e4245b198bf4a4f25f145b944